Probe is launched into claims a diabetic lawyer died after receiving ‘huge overdose from his faulty insulin pump’
- Lawyer died after being allegedly given four days’ worth of insulin in 48 minutes
- Paul McNairney using wearable insulin pump Omnipod before death last month
- Investigation has now been launched into device after the 39-year-old died
A lawyer died in his sleep after he was allegedly given four days’ worth of insulin in 48 minutes by a faulty medical device.
Paul McNairney, 39, had been using his Omnipod – a wearable insulin pump – after he was given it on the NHS in July.
But an investigation has now been launched into the device after the Type 1 diabetic, who was based in Glasgow, died last month.
Paul McNairney, 39, died in his sleep after he was allegedly given four days’ worth of insulin in 48 minutes by a faulty medical device
Mr McNairney had been using his Omnipod – a wearable insulin pump – after he was given it on the NHS in July
Lawyers for his family claim Mr McNairney, pictured, had dangerously low blood sugar levels after receiving 75 units of insulin in just under an hour – more than twice the maximum amount Omnipods are supposed to be able to deliver.
His life support was turned off three days after he was found unconscious in bed when his family were told he had suffered catastrophic and irreparable brain damage.
His husband Scott Craig, 42, has called for the pumps to be withdrawn, saying: ‘This device is used worldwide so people need to know what happened as even a single avoidable death is one too many.’
He added: ‘Paul was intelligent, kind and calm. He was also uncommonly humble and could instantly be friends with anyone.
An investigation has now been launched into the device after the Type 1 diabetic, who was based in Glasgow, died last month
‘But as well as the loss it’s the questions that make things worse…
‘Health boards need to stop using Omnipods right now until their integrity, and the safety of users, can be guaranteed.’
A spokesman for Omnipod manufacturer Insulet said that consumer safety was their ‘number one priority’.
The US firm added: ‘Insulet has been made aware of this unfortunate incident and is working with [medical authority] the MHRA to obtain the device for further investigation.
‘At this point, we do not have evidence of a device malfunction or performance issue.’
Source: Read Full Article
